HALO insider trading
Halozyme Therapeutics, Inc.
In the past 36 days, 2 insiders sold $15.7M.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
Helen Torley PRESIDENT AND CEO |
$6.6M 60,000 sh @ $110.18 |
−7.2% | Pre-scheduled | Oct 6, 2026 Filed Oct 8, 2026 |
Matthew L. Posard Director |
$568K 5,230 sh @ $108.54 |
−8.9% | Pre-scheduled | Oct 1, 2026 Filed Oct 2, 2026 |
Matthew L. Posard Director |
$2.0M 18,996 sh @ $107.74 |
−24.4% | Pre-scheduled | Sep 16, 2026 Filed Sep 17, 2026 |
Helen Torley PRESIDENT AND CEO |
$6.4M 60,000 sh @ $107.28 |
−7.2% | Pre-scheduled | Sep 9, 2026 Filed Sep 11, 2026 |